|
DETAILS
|
| COMPOSITION |
250/500 mg dispersible tablet/ Dry syrup
Each tablet contains 250/500 mg Cefadroxil IP equivalent to Cefadroxil anhydrous 250/500 mg ; Dry syrup: after reconstitution each 5 ml contains Cefadroxil IP equivalent to Cefadroxil anhydrous 125 mg. |
| INDICATIONS |
URTI, LRTI, UTI, SSTI, Bone and Joint infection and Dental infection |
| MODE OF ACTION |
Acts by inhibiting bacterial cell wall synthesis by activating autolytic enzyme of the cell wall. |
| ONSET OF ACTION |
30-60 minutes. |
| DURATION OF ACTION: |
12-16 hours |
| ADVERSE EFFECT : |
Nausea, epigastric distress, vomiting, diarrhoea, pseudomembranous colitis, vaginal itching and burning, dysuria have been infrequently reported . May cause transient elevation of serum transaminases, skin rash. |
| CONTRAINDICATION: |
Hypersensitivity to Cephalosporins. |
| SPECIAL PRECAUTION: |
Colitis and renal dysfunction. Use with caution in pregnancy and lactation |
| DRUG INTERACTION: |
Aminoglycosides, Oral Anti-coagulants, Chloramphenicol, Probenecid, Frusemide and Ethacrynic acid. |
| DOSAGE AND ADMINISTRATION: |
Adults- 500 mg - 1g once or twice daily
Children below 1 year- 25 mg/kg body wt daily in 2 divided doses
Children- 1-6 yrs- 250 mg twice daily
Children above 6 yrs - 500 mg. twice daily |
| PACKING |
BROTZU 250: Strip of 10 tablets
BROTZU 500: Strip of 4 tablets
BROTZU DRY SYRUP: 30 ml bottle |
Medicines for
Anti Diarrhoeal
Horn 
Tablets & Suspension